Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
University of California, Los Angeles · University of Michigan–Ann Arbor · +18 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,052
total citations
- FWCI
- 62.09
- Percentile
- 100%
- References
- 34
Citations per year
Authors
44Topics & keywords
Topics
Keywords
- Medicine
- Cyclophosphamide
- Mycophenolate
- Placebo
- Interstitial lung disease
- Clinical endpoint
- Internal medicine
- Mycophenolic acid
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.